Latest Partnerships News

Micro-X Ltd has secured a $4.4 million Australian Government grant to develop and trial a portable Head CT scanner designed for standard ambulances, aiming to transform emergency stroke care with faster diagnosis and treatment.

Genmin Limited advances its Baniaka iron ore project with PowerChina’s subsidiary Sinohydro submitting engineering and construction proposals that suggest potential capital cost reductions. Parallel funding discussions with Chinese partners are also progressing.

Cokal Limited has secured a binding agreement with PT Petrindo to jointly fund and develop the BBM Haul Road into an all-weather route, appointing PT Petrosea as contractor to support coal transport capacity growth.

Lakes Blue Energy has successfully drilled its Wombat-5 well to the planned depth in Victoria’s Gippsland Basin, revealing promising gas-saturated sands that echo previous successes.

Forrestania Resources has agreed to acquire a significant 7.37% stake in Kula Gold through a $1.87 million share subscription, reinforcing its strategic foothold in Western Australia's Southern Cross gold region.

Kula Gold has raised $2.5 million through a strategic placement to key investors, aiming to accelerate exploration at its Mt Palmer Gold Project amid a change in joint venture ownership.

Kula Gold has raised $2.5 million through a strategic share placement to key industry players, aiming to accelerate exploration at its Mt Palmer Gold Project.

Maronan Metals has released a Preliminary Economic Assessment for its Starter Zone project, revealing strong financial metrics and two viable development options – an onsite processing plant and a toll-treatment alternative.

MetalsTech Limited has completed a significant off-market block trade involving 4 million shares worth nearly $2 million, signaling notable shifts among its substantial shareholders.

Delorean Corporation has locked in a $14.5 million lower-cost loan facility with National Australia Bank to fund its SA1 Salisbury Bioenergy Project, refinancing existing debt and freeing capital for further bioenergy developments.

Algorae Pharmaceuticals has secured an exclusive licensing agreement with Sakar Healthcare to introduce five generic oncology medicines in Australia and New Zealand, marking its first commercial foray in the region.

Clover Corp has reported a standout FY25 with robust revenue and profit growth, driven by new product launches and strategic investments that strengthen its global supply chain and market reach.